Adalimumab for Inflammatory Osteoarthritis

NCT00686439 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: adalimumab
DRUG: adalimumab

Sponsor

University of Alberta